141 related articles for article (PubMed ID: 31327557)
1. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions.
Cognasse F; Garraud O
Transfus Clin Biol; 2019 Sep; 26(3):144-146. PubMed ID: 31327557
[TBL] [Abstract][Full Text] [Related]
2. Determination of predictors of severity for recipient adverse reactions during platelet product transfusions.
Sut C; Tariket S; Cognasse F; Garraud O
Transfus Clin Biol; 2017 Jun; 24(2):87-91. PubMed ID: 28479028
[TBL] [Abstract][Full Text] [Related]
3. [Platelets cytokines and their effects on platelet transfusion].
Cognasse F; Osselaer JC; Garraud O
Transfus Clin Biol; 2007 May; 14(1):69-78. PubMed ID: 17499538
[TBL] [Abstract][Full Text] [Related]
4. Platelet and TRALI: From blood component to organism.
Tariket S; Sut C; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
Transfus Clin Biol; 2018 Sep; 25(3):204-209. PubMed ID: 29631963
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand (CD154) involvement in platelet transfusion reactions.
Sahler J; Spinelli S; Phipps R; Blumberg N
Transfus Clin Biol; 2012 Jun; 19(3):98-103. PubMed ID: 22703674
[TBL] [Abstract][Full Text] [Related]
6. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
[TBL] [Abstract][Full Text] [Related]
7. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.
Blumberg N; Spinelli SL; Francis CW; Taubman MB; Phipps RP
Immunol Res; 2009 Dec; 45(2-3):251-60. PubMed ID: 19184537
[TBL] [Abstract][Full Text] [Related]
8. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.
Aloui C; Prigent A; Sut C; Tariket S; Hamzeh-Cognasse H; Pozzetto B; Richard Y; Cognasse F; Laradi S; Garraud O
Int J Mol Sci; 2014 Dec; 15(12):22342-64. PubMed ID: 25479079
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.
Refaai MA; Phipps RP; Spinelli SL; Blumberg N
Thromb Res; 2011 Apr; 127(4):287-91. PubMed ID: 21093892
[TBL] [Abstract][Full Text] [Related]
10. The causes and treatment of reactions to platelet transfusions.
Blumberg N; Phipps RP; Kaufman J; Heal JM
Transfusion; 2003 Feb; 43(2):291-2; author reply 292. PubMed ID: 12559029
[No Abstract] [Full Text] [Related]
11. Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury.
Tariket S; Hamzeh-Cognasse H; Laradi S; Arthaud CA; Eyraud MA; Bourlet T; Berthelot P; Garraud O; Cognasse F
Sci Rep; 2019 Aug; 9(1):12536. PubMed ID: 31467410
[TBL] [Abstract][Full Text] [Related]
12. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
13. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
[TBL] [Abstract][Full Text] [Related]
14. Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model.
Cognasse F; Sut C; Fromont E; Laradi S; Hamzeh-Cognasse H; Garraud O
Blood; 2017 Sep; 130(11):1380-1383. PubMed ID: 28720587
[No Abstract] [Full Text] [Related]
15. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.
Nguyen KA; Hamzeh-Cognasse H; Sebban M; Fromont E; Chavarin P; Absi L; Pozzetto B; Cognasse F; Garraud O
PLoS One; 2014; 9(5):e97082. PubMed ID: 24830754
[TBL] [Abstract][Full Text] [Related]
16. Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events.
Hamzeh-Cognasse H; Laradi S; Osselaer JC; Cognasse F; Garraud O
Vox Sang; 2015 Feb; 108(2):205-7. PubMed ID: 25334045
[TBL] [Abstract][Full Text] [Related]
17. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein.
Li T; Yang Y; Li Y; Wang Z; Ma F; Luo R; Xu X; Zhou G; Wang J; Niu J; Lv G; Crispe IN; Tu Z
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 34964720
[TBL] [Abstract][Full Text] [Related]
18. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
Hamzeh-Cognasse H; Damien P; Nguyen KA; Arthaud CA; Eyraud MA; Chavarin P; Absi L; Osselaer JC; Pozzetto B; Cognasse F; Garraud O
Transfusion; 2014 Mar; 54(3):613-25. PubMed ID: 23944651
[TBL] [Abstract][Full Text] [Related]
19. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
[TBL] [Abstract][Full Text] [Related]
20. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
